EUVIMEDEUVIMED entdecken
Crossref

Association of Intellectual and Developmental Disabilities With Worse Outcomes After Surgical Treatment of Cancer

Vivian Resende, Selamawit Woldesenbet, Erryk Katayama, Muhammad Musaab Munir, Henrique Araújo Lima, Mujtaba Khalil, Karol Rawicz-Pruszyński, Muhammad Muntazir Mehdi Khan, Usama Waqar, Parit Mavani, Yutaka Endo, Timothy M Pawlik

Journal of the National Comprehensive Cancer Network · 2024

DOI: 10.6004/jnccn.2024.7038 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2024. Verfasst von Vivian Resende und 11 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Surgery, The Ohio State University, Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH. Hauptthemen laut MEDLINE: Neoplasms, Intellectual Disability, Developmental Disabilities. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with intellectual and developmental disabilities (IDD) face unique challenges resulting in disparities in their health care. We sought to define the effect that IDD had on achievement of a “textbook outcome” (TO) following a cancer operation among a nationally representative cohort of patients.

Methods

Data on patients who underwent surgery for a malignant indication, including lung, breast, liver, biliary tract, pancreas, and colorectal, between 2014 and 2020 were extracted from the 100% Medicare Standard Analytical Files database. The association of IDD with TO (defined as the absence of postoperative complications, extended length of stay, 90-day readmission, and 90-day mortality), expenditures, and discharge status was assessed using multivariable logistic regression.

Results

Among 500,472 Medicare beneficiaries, 4,326 (0.9%) with IDD had a cancer diagnosis (breast, n=481; lung, n=419; hepatobiliary, n=194; pancreas, n=145; colorectal, n=3,087). Although overall incidence of TO was 50.5%, patients with IDD were less likely to achieve a TO than those without (37.1% vs 50.6%, respectively; odds ratio [OR], 0.50; 95% CI, 0.46–0.53; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsIntellectual DisabilityDevelopmental DisabilitiesHumansFemaleMaleAgedUnited StatesPostoperative ComplicationsPatient ReadmissionAged, 80 and overLength of StayMedicareTreatment Outcome

Autor:innen und Institutionen

  • 1Department of Surgery, The Ohio State University, Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH.
  • 2Federal University of Minas Gerais School of Medicine, Belo Horizonte, Brazil.
  • 3Department of Surgical Oncology, Medical University of Lublin, Poland.
  • 4Medical College, Aga Khan University, Karachi, Pakistan.

Zitieren

APA

Resende, V., Woldesenbet, S., Katayama, E., Munir, M. M., Lima, H. A., Khalil, M., Rawicz-Pruszyński, K., Khan, M. M. M., Waqar, U., Mavani, P., Endo, Y., & Pawlik, T. M. (2024). Association of Intellectual and Developmental Disabilities With Worse Outcomes After Surgical Treatment of Cancer. Journal of the National Comprehensive Cancer Network. https://doi.org/10.6004/jnccn.2024.7038

Vancouver

Resende V, Woldesenbet S, Katayama E, Munir MM, Lima HA, Khalil M, et al. Association of Intellectual and Developmental Disabilities With Worse Outcomes After Surgical Treatment of Cancer. Journal of the National Comprehensive Cancer Network. 2024. doi:10.6004/jnccn.2024.7038

BibTeX
@article{Resende2024,
  author = {Resende, Vivian and Woldesenbet, Selamawit and Katayama, Erryk and Munir, Muhammad Musaab and Lima, Henrique Araújo and Khalil, Mujtaba and Rawicz-Pruszyński, Karol and Khan, Muhammad Muntazir Mehdi and Waqar, Usama and Mavani, Parit and Endo, Yutaka and Pawlik, Timothy M},
  title = {Association of Intellectual and Developmental Disabilities With Worse Outcomes After Surgical Treatment of Cancer},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2024},
  doi = {10.6004/jnccn.2024.7038}
}
Kostenlos starten →